Similar articles for PMID: 35676753

Year	Number of Results
2001	1
2004	1
2007	2
2008	1
2009	2
2010	2
2011	2
2012	2
2013	1
2014	1
2015	6
2016	5
2017	6
2018	12
2019	8
2020	18
2021	15
2022	21
2023	3

1

PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer.

Liang H. Liang H. Cancer Biol Med. 2022 Jun 9;19(5):565-8. doi: 10.20892/j.issn.2095-3941.2022.0244. Online ahead of print. Cancer Biol Med. 2022. PMID: 35676753 Free PMC article. No abstract available.

2

[Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].

Zhu Z. Zhu Z. Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Oct 25;21(10):1087-1092. Zhonghua Wei Chang Wai Ke Za Zhi. 2018. PMID: 30370504 Review. Chinese.

3

[Progress in conversion therapy for stage IV gastric cancer].

Liang H. Liang H. Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Feb 25;24(2):107-111. doi: 10.3760/cma.j.cn.441530-20201215-00661. Zhonghua Wei Chang Wai Ke Za Zhi. 2021. PMID: 33508914 Chinese.

4

Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy.

Hayano K, Watanabe H, Ryuzaki T, Sawada N, Ohira G, Kano M, Uesato M, Matsubara H. Hayano K, et al. Surg Case Rep. 2020 Sep 24;6(1):219. doi: 10.1186/s40792-020-00984-w. Surg Case Rep. 2020. PMID: 32970254 Free PMC article.

5

Conversion Surgery for Stage IV Gastric Cancer.

Zhang F, Huang X, Song Y, Gao P, Zhou C, Guo Z, Shi J, Wu Z, Wang Z. Zhang F, et al. Front Oncol. 2019 Nov 7;9:1158. doi: 10.3389/fonc.2019.01158. eCollection 2019. Front Oncol. 2019. PMID: 31788445 Free PMC article. Review.

6

The long-term survival of stage IV gastric cancer patients with conversion therapy.

Yamaguchi K, Yoshida K, Tanahashi T, Takahashi T, Matsuhashi N, Tanaka Y, Tanabe K, Ohdan H. Yamaguchi K, et al. Gastric Cancer. 2018 Mar;21(2):315-323. doi: 10.1007/s10120-017-0738-1. Epub 2017 Jun 14. Gastric Cancer. 2018. PMID: 28616743 Free PMC article.

7

Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification.

Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y. Yoshida K, et al. Gastric Cancer. 2016 Apr;19(2):329-338. doi: 10.1007/s10120-015-0575-z. Epub 2015 Dec 7. Gastric Cancer. 2016. PMID: 26643880 Free PMC article. Review.

8

Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.

Kinoshita J, Fushida S, Tsukada T, Oyama K, Okamoto K, Makino I, Nakamura K, Miyashita T, Tajima H, Takamura H, Ninomiya I, Ohta T. Kinoshita J, et al. Eur J Surg Oncol. 2015 Oct;41(10):1354-60. doi: 10.1016/j.ejso.2015.04.021. Epub 2015 May 15. Eur J Surg Oncol. 2015. PMID: 26028256 Free article.

9

Clinical Significance of Serum Biomarkers in Stage IV Non-Small-Cell Lung Cancer Treated with PD-1 Inhibitors: LIPI Score, NLR, dNLR, LMR, and PAB.

Chen J, Wei S, Zhao T, Zhang X, Wang Y, Zhang X. Chen J, et al. Dis Markers. 2022 Jul 30;2022:7137357. doi: 10.1155/2022/7137357. eCollection 2022. Dis Markers. 2022. PMID: 35945957 Free PMC article.

10

International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1).

Yoshida K, Yasufuku I, Terashima M, Young Rha S, Moon Bae J, Li G, Katai H, Watanabe M, Seto Y, Hoon Noh S, Kwang Yang H, Ji J, Baba H, Kitagawa Y, Morita S, Nishiyama M, Kodera Y; CONVO‐GC‐1 Study Group, Federation of Asian Clinical Oncology (FACO). Yoshida K, et al. Ann Gastroenterol Surg. 2021 Oct 20;6(2):227-240. doi: 10.1002/ags3.12515. eCollection 2022 Mar. Ann Gastroenterol Surg. 2021. PMID: 35261948 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year